Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in Type 2 Diabetes Uncontrolled with Metformin and Sulphonylurea
NCT01099137Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Bundang Hospital. Started Jan 2010; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01099137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099137.